Vasundhara Rasayans Ltd vs SUN PHARMACEUTICAL IND L

A side-by-side comparison of Vasundhara Rasayans Ltd (538634) and SUN PHARMACEUTICAL IND L (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, SUN PHARMACEUTICAL IND L leads 538634 vs SUNPHARMA on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability04
  • Growth02
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

538634 takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

9.60
P/E ratio
38.71
1.35
P/B ratio
20.07
1.15%
Dividend yield
0.86%
₹13.37
EPS
₹47.84

Profitability

SUNPHARMA takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

15.20%
Return on equity
16.00%
16.56%
Return on capital
21.00%
12.09%
EBITDA margin
28.00%
12.50%
Net margin
19.69%

Growth

SUNPHARMA takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-1.94%
Revenue CAGR (3Y)
10.03%
1.06%
Profit CAGR (3Y)
10.57%

Size & financial health

SUNPHARMA takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹56 Cr
Market cap
₹4.41L Cr
₹34 Cr
Revenue
₹58,462 Cr
₹4 Cr
Net profit
₹11,509 Cr
0.04
Debt / equity
0.61
Vasundhara Rasayans Ltd
  • + ["Company has reduced debt.", "Company is almost debt free."]
  • ["The company has delivered a poor sales growth of 9.51% over past five years.", "Earnings include an other income of Rs.2.90 Cr.", "Debtor days have increased from 60.7 to 76.2 days."]
SUN PHARMACEUTICAL IND L
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years."]
Vasundhara Rasayans Ltd full analysis SUN PHARMACEUTICAL IND L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

538634 vs SUNPHARMA: Share Price, Valuation & Which to Buy | DocStoX